But, in a series of 1487 CRC patients including 185 patients with PIK3CA-mutated tumors, Kothari and colleagues did not confirm the relationship between aspirin use and improved survival in patients with stage II-III disease 44. The gene discussed is PIK3CA; the disease is colorectal carcinoma.